anthony shuker scientific Poster Session
Poster Session Details

 

The Executive Committee invites the submission of abstracts from Georgia-based scientists for this year's poster session. Abstracts must be submitted electronically online. The Online submission period has ended. If you applied, you will receive a notification on whether or not your poster was accepted 2 weeks in advance of the Summit.

 

This opportunity to participate in the Poster Session is open to representatives from Georgia-based academia, research institutes and industry alike, and we especially encourage students and post-doctoral fellows to participate. Abstracts will be subject to the same scientific review as for any national or regional meeting. The scientific content of poster presentations should reflect one of the following categories:

  • Agricultural Biotechnology
  • Bioenergy
  • Cell Therapy & Tissue Engineering
  • Drug Discovery and Development
  • Food and Nutrition
  • Healthcare IT
  • Industrial Production
  • Medical Technology and Devices
  • Molecular and Biological Research
  • Nanotechnology

For student, post-doctoral or non-profit organization abstracts selected, the corresponding author of each poster will receive complimentary registration to the Summit. In addition, posters submitted by students will be eligible for a limited number of poster awards.

 

Submissions will be reviewed on a rolling basis. Abstract Submission Deadline has passed.


For more information contact Kristen Morris at Informed Horizons, LLC at +1 770 573 3020+1 770 573 3020 or kmorris@informedhorizons.com.

Poster Session Judges

Richard A. Hillstead, Ph.D, FAHA
Partner, Georgia Venture Partners  

Rick Hillstead has been actively involved in the design and development of medical devices since 1986. He held several progressive, Product Research and Development positions with Cordis Corporation (Johnson & Johnson) from 1987 to 1993 where he pioneered the Cordis Corporate Research coronary stenting program. He then directed new technology development for Novoste Corporation from 1993 until 1999 primarily focusing on intravascular brachytherapy catheters and systems for the treatment of coronary restenosis utilizing a revolutionary technology jointly developed with Emory University in Atlanta. In 1999 he became a founding member The Innovation Factory, a private medical device incubator in Duluth, GA. where he co-founded Neuronetics, another Emory technology targeting a non-invasive treatment of depression. He was also a principal partner and founding member in Accuitive Medical Ventures I and II (2004 – 2007). Accuitive Medical Ventures is a $225M venture capital fund dedicated to medical devices. At The Innovation Factory he served as Chief Science Officer and was primarily responsible for technical due diligence and deal structure in areas of Interventional Cardiology and Orthopaedics.  He is currently a partner with Georgia Venture Partners, Atlanta GA. and president of Richard A. Hillstead, Inc., a medical device consulting firm.

Dr. Hillstead is also Chairman of Biofisica Inc., leading the company in developing applications for its proprietary and revolutionary wound healing technology. He is a past Chairman and co-founder of Cerebral Vascular Applications, Inc. (CVA), a company dedicated to reducing the incidence of stroke. He is an accomplished inventor named on more than seventy five issued U.S. patents and patent applications and dozens of international patents. His intellectual property has been referenced in over three thousand issued U.S. patents and pending patent applications. He has given expert testimony in the field of cardiology devices in US courts and arbitrations and served as an expert witness to the High Court of Justice in the UK and testimony to the European Patent Office.  He has participated actively in the development of numerous, commercially successful and innovative medical devices.

Dr. Hillstead holds a B.S. in Engineering Management and an M.B.A. from Nova Southeastern University and a PhD. In Business Administration from Southwest University. He is a Fellow of the American Heart Association (FAHA) on the Council of Clinical Cardiology, Fellow on the Council on Nutrition, Physical Activity, and Metabolism, and a current member of the Stroke Council. He is a former Entrepreneur-in-residence with the US Food and Drug Administration and continues to work with the FDA on innovative programs.  He resides in Suwanee GA.

Carol McMahon
Independent Contractor, Healthcare Law | HIPAA Compliance


Carol E. McMahon, J.D. is an independant contractor specializing in Healthcare Law | HIPAA Compliance. Previously she was the Managing Director for Research at the Texas Tech University Health Sciences Center in El Paso, where she was responsible for the oversight of the research  administration, technology transfer, research compliance, and immigration offices.
She received her B.A. from Boston University and her J.D. from New England School of Law in Boston. She is a member of the bars of Massachusett s and Georgia. Prior to Texas Tech University Health Sciences Center in El Paso, she was the Associate General Counsel for Research at Emory University and Emory Healthcare in Atlanta, where she was counsel to all of the various research offices and the technology transfer office, and active in the Georgia State Bar Intellectual Property Law section and the Women in Law and Science organization. She moved to Atlanta from Boston, where she was the Associate General Counsel for Research at Tufts New England Center and for a period of time the Director of the Technology Transfer Office and the Manager of the Clinica  Trials Office. She has served as Co-Chair of the Research Affinity Group of the American Health Lawyers Association and is active in several of the research committees in the American Bar Association.

Stacy (Williams) Shuker Reece, Ph.D.
Connector, Healthcare and Innovation
Down South Innovation; SafelyLocked, LLC;  Massie R&D Tax Credits

Guidelines
Abstract Submission
To submit an abstract click on the button above and complete the form. Abstract presenters MAY NOT be changed after acceptance, without consent of the Executive Committee.

Abstract Submission Deadline has been EXTENDED to Monday, September 4, 2014.

Abstract Judging
As a reminder, if your Abstract is selected, you will be required to attend the Summit on Oct. 16 at the Georgia International Convention Center judging.

Sample Abstract
To view a sample abstract, click here. The sample form is an Adobe Acrobat document. If your computer cannot read the sample, please click here to download Adobe's free Acrobat Reader.

Abstract Guidelines
Format
The body of the uploaded abstract submission should not exceed 450 words; this limit excludes the title, authors and affiliations. Clearly define all concepts and abbreviations at first use. If English is not your primary language, attempt to have your abstract reviewed by a native English speaker. To be acceptable, abstracts shall contain a concise statement of the research. It is recommended that the author follow the structured format below:

Title (not included in 450 word limit)
Use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Species names should be spelled out at first use. Italicize scientific names of organisms (example: Staphylococcus aureus).

Authors (not included in 450 word limit)
Authors' names should be entered using initial(s) for the first and middle names followed by the full last name, with presenting author underlined (e.g. PM Coker, J Ballard, and AP Deutsch).

Affiliations (not included in 450 word limit)
All affiliations should follow the last author's name and be referenced with superscript numbers. Each author should be listed by institution, city, and state (2 letter postal abbreviation) or country.

Background
State the problem under investigation or a hypothesis. No figures or tables are allowed.

Methods
Explain the experimental methods used. No figures or tables are allowed.

Results
List the essential results obtained in summary form, with enough quantitative data to permit evaluation by reviewers. No figures or tables are allowed.

Conclusion
Summarize the findings. It is unacceptable to use statements such as "the results will be discussed". No figures or tables are allowed.

Additional Abstract Information
In addition to the uploaded abstract, the following additional information will be collected on the abstract submission form:

Abstract Category
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Organizing Committee reserves the right to reassign your abstract to a more appropriate category.

    Agricultural Biotechnology
    Bioenergy
    Cell Therapy & Tissue Engineering
    Drug Discovery and Development
    Food and Nutrition
    Healthcare IT
    Industrial Production
    Medical Technology and Devices
    Molecular and Biological Research
    Nanotechnology

Abstract Title (should be the same as in the uploaded abstract)
Use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Species names should be spelled out at first use. Italicize scientific names of organisms (example: Staphylococcus aureus).

Published Abstract Book
Accepted abstracts will be standardized in font and presentation. Any scientific or typographic error that appears in the submitted abstract will appear in the printed abstract.

To submit your abstract on-line, please complete and submit the on-line submission form, by clicking here.

Why a poster session?

Georgia Bio understands that research takes time to accumulate, compile, and publish in an understandable format. As a Research Presenter you want to get this valuable information into as many of the right hands as possible and the Summit Poster Session is a highly effective way to do this. Apply for the poster session so you can communicate your research topic to a wide audience in Georgia's bioscience industry.

This year the poster session will take place in the exhibition hall.

 

Quick Links